Physician profile
David Lewis
NPI 1760522817
$1,113.25
in general payments reported to CMS, 2019-2025
11 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.51 · 2020: $111 · 2021: $45.21 · 2022: $162 · 2023: $167 · 2024: $319 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $395.05 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $177.24 | 2022-2025 | Vabysmo |
| Astellas Pharma US INC | $144.93 | 2023-2025 | Izervay |
| Allergan, INC. | $92.33 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $92.19 | 2021-2025 | Healon Duet Pro, Tecnis Simplicity |
| Alcon Vision LLC | $84.09 | 2019-2024 | Clareon |
| Apellis Pharmaceuticals, INC. | $46.57 | 2023-2025 | Syfovre |
| Aerie Pharmaceuticals, INC. | $31.00 | 2019-2020 | |
| Rxsight INC | $24.24 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Abbvie INC. | $13.90 | 2023 | |
| Omeros Corporation | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.